Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,552,000 | 877,000 | 1,150,000 | 403,300 | 1,458,500 |
| Marketable Securities | 2,377,000 | 712,000 | 487,000 | 1,108,700 | 560,100 |
| Receivables | 2,914,000 | 2,527,000 | 2,252,000 | 2,024,000 | 1,665,000 |
| Inventories | 1,828,000 | 1,773,000 | 1,589,000 | 1,384,100 | 1,264,900 |
| Other current assets | 1,260,000 | 931,000 | 990,000 | 1,232,300 | 839,900 |
| TOTAL | $9,931,000 | $6,820,000 | $6,468,000 | $6,152,400 | $5,788,400 |
| Non-Current Assets | |||||
| PPE Net | 4,415,000 | 4,137,000 | 3,850,000 | 3,472,600 | 3,073,200 |
| Investments And Advances | 1,756,000 | 1,340,000 | 1,163,000 | 544,900 | 724,300 |
| Other Non-Current Assets | 2,200,000 | 3,039,000 | 3,186,000 | 2,559,400 | 1,512,600 |
| TOTAL | $8,371,000 | $8,516,000 | $8,199,000 | $6,576,900 | $5,310,100 |
| Total Assets | $18,302,000 | $15,336,000 | $14,667,000 | $12,729,300 | $11,098,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 971,000 | 765,000 | 913,000 | 715,300 | 524,900 |
| Accrued Expenses | 614,000 | 477,000 | 436,000 | 421,300 | 419,000 |
| Other current liabilities | 1,716,000 | 1,023,000 | 1,164,000 | 1,192,800 | 930,900 |
| TOTAL | $7,192,000 | $5,305,000 | $5,640,000 | $5,187,200 | $4,825,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 527,000 | 729,000 | 687,000 | 833,000 | 604,200 |
| aiOther Non-Current Liabilities | 1,576,000 | 1,213,000 | 1,133,000 | 1,036,400 | 1,132,800 |
| TOTAL | $2,300,000 | $2,098,000 | $2,073,000 | $2,035,500 | $1,948,700 |
| Total Liabilities | $9,492,000 | $7,403,000 | $7,713,000 | $7,222,700 | $6,774,600 |
| Shareholders' Equity | |||||
| Common Shares | 70,000 | 69,000 | 34,000 | 34,300 | 34,000 |
| Retained earnings | 11,439,000 | 9,349,000 | 8,017,000 | 6,858,900 | 5,944,500 |
| Other shareholders' equity | -4,434,000 | -2,731,000 | -1,343,000 | -1,006,800 | -553,000 |
| TOTAL | $8,810,000 | $7,933,000 | $6,954,000 | $5,506,600 | $4,323,900 |
| Total Liabilities And Equity | $18,302,000 | $15,336,000 | $14,667,000 | $12,729,300 | $11,098,500 |